Biotechnology, Neuorscience
APRINOIA Therapeutics has raised $4.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
APRINOIA Therapeutics's investors include IMM Investment, IMM Private Equity, DCI Partners, Alzheimer's Drug Discovery Foundation, Company K Partners.
APRINOIA Therapeutics is headquartered in Boston, United States.
Biotechnology, Neuorscience
APRINOIA Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"APRINOIA Therapeutics — Funding & Investors." VCBacked, September 11, 2023, https://www.vcbacked.co/company/aprinoia-therapeutics. Accessed November 12, 2026.
VCBacked. (2023). APRINOIA Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/aprinoia-therapeutics
{{cite web |title=APRINOIA Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aprinoia-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at APRINOIA Therapeutics? Request a listing update